The post-thrombotic syndrome (PTS) is a form of chronic venous insufficiency secondary to
prior deep vein thrombosis (DVT). It affects up to 50% of patients after proximal DVT. There …

Introduction Post-thrombotic syndrome (PTS) is a burdensome long-term complication of
deep vein thrombosis (DVT). Recent studies have suggested that rivaroxaban may reduce …

The novel direct oral anticoagulants (DOAC) have been shown to be at least as effective as
and safer than conventional anticoagulants for the initial and long-term treatment of venous …

The postthrombotic syndrome (PTS) is chronic venous insufficiency secondary to a prior
deep vein thrombosis (DVT). It is the most common complication of venous …

Background Studies suggest that the direct factor Xa inhibitor rivaroxaban compared to
warfarin reduces the risk of post‐thrombotic syndrome (PTS) after deep vein thrombosis …

The identification of specific post-thrombotic complications as well as an increased
appreciation of the importance of patient-reported outcome measures have triggered an …

Introduction Postthrombotic syndrome (PTS) remains associated with significant clinical and
economic burden. This study aimed to investigate known and novel predictors of the …

Abstract Objective Direct oral anticoagulants (DOACs) have been recommended for the
treatment of deep vein thrombosis (DVT). However, the benefits are uncertain for the …

A previously published review focused on generic and disease-specific patient-reported
outcome measures (PROMs) relevant to vascular surgery but limited to arterial conditions …

Reported here is a simple and rapid static headspace gas chromatography (SHS-GC)
method for the determination of trace solvents including ethanol, isopropanol, n-butanol, 1, 4 …